Dublin, March 31, 2026 (GLOBE NEWSWIRE) -- The "Radiation Oncology Treatment Planning Software Market Report 2026" has been added to ResearchAndMarkets.com's offering. The report offers in-depth analysis and insights into the market size, regional shares, competitor strategies, and emerging trends.
The radiation oncology treatment planning software market has witnessed robust growth, expanding from $2.51 billion in 2025 to an anticipated $2.74 billion in 2026, reflecting a compound annual growth rate (CAGR) of 9.1%. This surge is driven by the increasing global cancer incidence, adoption of radiation therapy techniques, advancements in medical imaging technologies, and the expansion of oncology treatment centers.
Future projections indicate continued growth, with the market expected to reach $3.85 billion by 2030 at a CAGR of 8.9%. Factors such as the integration of AI in clinical decision support, growth in precision medicine, and demand for reduced treatment side effects play a significant role in this growth. Emerging trends include AI-assisted treatment planning, personalized radiation therapy, and workflow automation in oncology planning.
The prevalence of cancer is a primary driver of growth in this market, fueled by factors like aging populations, increased exposure to risk factors, advancements in diagnostic technologies, and improved cancer survival rates. Radiation oncology treatment planning software leverages imaging data to precisely target tumors, enhancing treatment efficacy while minimizing side effects. For instance, a report by the American Cancer Society in January 2024 noted a 3.2% increase in skin cancer cases in the US from 2023, underpinning the rising demand for this technology.
Leading players in the market, such as Accuray Incorporated and GE HealthCare Technologies, Inc., are investing heavily in advanced features. Accuray introduced the Accuray Precision Treatment Planning System, which adapts in real-time to changes in tumor dynamics, enhancing precision and minimizing exposure to healthy tissue. GE HealthCare, through its acquisition of MIM Software Inc., aims to enhance precision care and clinical workflow efficiency.
Key companies in this market include Siemens Healthineers AG, Koninklijke Philips N.V., Varian Medical Systems Inc., Elekta AB, Brainlab AG, and more. Among regions, North America led the market in 2025, while Asia-Pacific is projected as the fastest-growing region. The report covers regions such as Asia-Pacific, Western Europe, North America, and countries including the USA, UK, China, and India.
Reasons to Purchase:
- Access a global perspective with a report covering 16 geographies.
- Evaluate the impact of macro factors like geopolitical conflicts, trade policies, and evolving regulations.
- Formulate regional and country strategies based on detailed local data.
- Spot investment opportunities in growth segments.
- Use forecast data to outperform competitors and identify market drivers.
- Gain insights into customer behavior through end-user analysis.
- Benchmark against competitors by analyzing market share, innovation, and brand strength.
- Assess the total addressable market (TAM) and attractiveness scoring for strategic positioning.
- Utilize high-quality data for internal and external presentations.
- Receive the latest data along with an Excel data sheet for easy analysis.
- Benefit from an Excel dashboard for quick data retrieval.
Markets Covered:
- By Type: Patient Information Systems, Treatment Planning Systems
- By Therapy Type: Stereotactic Radiosurgery (SRS), IMRT, and others
- By End-User: Hospitals, Research Centers, Government Institutions, and more
Notable Companies: Siemens Healthineers AG, GE Healthcare, Varian, and others
Key Geographies: Australia, Brazil, China, France, and more
Regions: Asia-Pacific, Europe, North America, and others
Time Series: Historic data over five years and forecasts for the next ten years
Data Parameters: Market size ratios, GDP proportions, and spending data.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 250 |
| Forecast Period | 2026-2030 |
| Estimated Market Value (USD) in 2026 | $2.74 Billion |
| Forecasted Market Value (USD) by 2030 | $3.85 Billion |
| Compound Annual Growth Rate | 8.9% |
| Regions Covered | Global |
The companies featured in this Radiation Oncology Treatment Planning Software market report include:
- Siemens Healthineers AG
- Koninklijke Philips N.V.
- GE Healthcare Technologies Inc.
- Varian Medical Systems Inc.
- Elekta AB
- Brainlab AG
- IBA Worldwide SA
- Canon Medical Systems Corporation
- ViewRay Inc.
- RaySearch Laboratories AB
- Vision RT Ltd.
- C-RAD
- MVision AI
- DOSIsoft SA
- Mirada Medical Ltd.
- Radformation Inc
- Prowess Inc
- Mevion Medical Systems
- Oncology Systems Limited
- Spectronic Medical AB
- MeVis Medical Solutions AG
- Lifeline Software Inc
- Sun Nuclear Corporation
- Shenzhen Mindray Bio-Medical Electronics Co Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/m321vm
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
